From PharmaKureFeb 29 2024Reviewed by Lily Ramsey, LLM PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease and other neurodegenerative diseases, today announces a new epigenetics collaboration with Sheffield Hallam University. This partnership will focus on ‘gene-based environmental biomarkers,’ known as epigenetic markers, for calculating risk scores for Alzheimer’s disease.
“We have been working on the relationship of environmental stresses with respect to brain diseases.” Professor Reynolds has published over 300 papers on the pathology of neurotransmitter systems involved in psychiatric disorders and now focuses on epigenetics effects in neurodiseases.
Education Education Latest News, Education Education Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: blogpreston - 🏆 82. / 55 Read more »
Source: BBCWestScot - 🏆 85. / 53 Read more »
Source: BBCScienceNews - 🏆 87. / 53 Read more »
Source: TheEconomist - 🏆 6. / 92 Read more »